United Cannabis (OTCMKTS:CNAB) VP Tony Verzura sold 97,050 shares of the firm’s stock in a transaction that occurred on Wednesday, April 18th. The stock was sold at an average price of $1.16, for a total transaction of $112,578.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Tony Verzura also recently made the following trade(s):

  • On Monday, April 16th, Tony Verzura sold 12,262 shares of United Cannabis stock. The stock was sold at an average price of $1.24, for a total transaction of $15,204.88.
  • On Monday, March 19th, Tony Verzura sold 25,000 shares of United Cannabis stock. The stock was sold at an average price of $1.25, for a total transaction of $31,250.00.
  • On Wednesday, February 14th, Tony Verzura sold 171,865 shares of United Cannabis stock. The stock was sold at an average price of $1.16, for a total transaction of $199,363.40.
  • On Friday, February 9th, Tony Verzura sold 78,763 shares of United Cannabis stock. The stock was sold at an average price of $1.22, for a total transaction of $96,090.86.
  • On Thursday, February 1st, Tony Verzura sold 40,749 shares of United Cannabis stock. The stock was sold at an average price of $1.20, for a total transaction of $48,898.80.

Shares of OTCMKTS:CNAB opened at $1.09 on Friday. United Cannabis has a 1-year low of $0.54 and a 1-year high of $2.50.

ILLEGAL ACTIVITY NOTICE: “Tony Verzura Sells 97,050 Shares of United Cannabis (CNAB) Stock” was first reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another domain, it was stolen and reposted in violation of US & international trademark & copyright laws. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2018/04/21/tony-verzura-sells-97050-shares-of-united-cannabis-cnab-stock.html.

United Cannabis Company Profile

United Cannabis Corporation owns intellectual properties related to growth, production, manufacture, marketing, management, utilization, and distribution of medical marijuana and marijuana infused products in the United States. The company focuses on developing therapeutics, including Prana Bio Nutrient Medicinal products for supplement deficiencies related to the endocannabinoid system, including pain, neuropathy, arthritis, MS, IBS, autism, seizures, eczema, sleep, anxiety, head trauma, opioid dependency, and clinical endocannabinoid deficiencies; and Prana Aromatherapy Transdermal Roll-on line that provides targeted and large surface relief with combinations of aromatherapy.

Insider Buying and Selling by Quarter for United Cannabis (OTCMKTS:CNAB)

Receive News & Ratings for United Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.